CD19 and acute lymphoblastic leukemia: For example, OS for ALL patients treated with CD19 Si-CAR T cells [3,30] was close to those with CD22 Si-CAR T cells [62], which was shorter than those treated with CD19/CD22 Bi-CART cells [30].